Surgical reintervention in acromegaly: Is it still worth trying?

Endocrine Practice

Volumn 15, Issue 5, 2009, Pages 431-437

  De Los Monteros, Ana Laura Espinosa ^a   González, Baldomero ^a   Vargas, Guadalupe ^a   Sosa, Ernesto ^a   Guinto, Gerardo ^a   Mercado, Moisés ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

ACROMEGALY; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; REOPERATION; RETROSPECTIVE STUDY; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME;

ACROMEGALY; ADULT; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70449731062     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP09066.ORR     Document Type: Article

References (16)

1. Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical "cure." Eur J Endocrinol. 2005;152:379-387.
2. Kreutzer J, Vance ML, Lopes MB, Laws ER Jr. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab. 2001;86:4072-4077.
3. Laws ER, Vance ML, Thapar K. Pituitary surgery for the management of acromegaly. Horm Res. 2000;53(suppl 3):71-75.
4. Biermasz N, van Dulken H, Roelfsema F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab. 2000;85:4596-4602.
5. Espinosa de los Monteros AL, Sosa E, Cheng S, et al. Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status. Clin Endocrinol (Oxf). 2006;64:245-249.
6. Kurosaki M, Luedecke DK, Abe T. Effectiveness of secondary transnasal surgery in GH secreting pituitary macroadenomas. Endocr J. 2003;50:635-642.
7. Abe T, Lüdecke DK. Recent results of secondary transnasal surgery for residual or recurring acromegaly. Neurosurgery. 1998;42:1013-1021.
8. Long H, Beauregard H, Somma M, Comtois R, Serri O, Hardy J. Surgical outcome after repeated transsphenoidal surgery in acromegaly. J Neurosurg. 1996;85:239-247.
9. Colao A, Attanasio R, Pivonello R, et al. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab. 2006;91:85-92.
10. Jallad RS, Musolino NR, Kodaira S, Cescato VA, Bronstein MD. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue? Clin Endocrinol (Oxf). 2007;67:310-315.
11. Jenkins PJ, Bates P, Carson MN, Stewart PM, Wass JA. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulinlike growth factor-I in patients with acromegaly. J Clin Endocrinol Metab. 2006;91:1239-1245.
12. Espinosa de los Monteros AL, Mercado M, Sosa E, et al. Changing patterns of insulinlike growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly. J Neurosurg. 2002;97:287-292.
13. Erturk E, Tuncel E, Kiyici S, Ersoy C, Duran C, Imamoglu S. Outcome of surgery for acromegaly performed by different surgeons: importance of surgical experience. Pituitary. 2005;8:93-97.
14. Castinetti F, Taieb D, Kuhn JM, et al. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab. 2005;90:4483-4488.
15. Sosa E, Espinosa de los Monteros AL, González B, Vargas G, Mier F, Mercado M. Treatment of acromegaly with octreotide LAR [article in Spanish]. Rev Med Inst Mex Seguro Soc. 2008;46:651-658.
16. Jallad RS, Musolino NR, Salgado LR, Bronstein MD. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution. Clin Endocrinol (Oxf). 2005;63:168-175.